Primologo
Tagdisability Tagline
Home Assistance Disabilities Fun Sign In

Report a Problem

4 Primos
Primo
Multiple Dose Clinical Trial Of TorreyPines Therapeutics' Tezampanel Demonst Popoff
0 Comments | Share | 134 Views | Problem? | 02/06/08
Linked From Medical News Today : TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) announced that data from its multiple dose clinical trial of tezampanel, an antagonist of the AMPA and k

Thanks for reporting this problem

We appreciate you notifying us of problem content so we can repair or eliminate it. Reporting problem content is as important as indicating Primo content since both allow us to improve the quality of our site. Please select the specific problem and add additional details in the box if needed.




: